Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hypothalamo-pituitary-gonadal axis is an integrated neuroendocrine system comprising the hypothalamus, pituitary gland, and gonads (ovaries or testes). It regulates vital functions including reproductive development, sexual maturation, fertility, and aspects of aging, primarily through complex hormone cascades. Gonadotropin-releasing hormone (GnRH), secreted by the hypothalamus, stimulates the pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which then act on the gonads to regulate production of sex steroids (estrogen, progesterone, testosterone) and gametogenesis. The system features prominent feedback loops, with sex steroids modulating upstream hormone release. Regulatory molecules such as kisspeptin, activin, inhibin, and follistatin also play key roles in axis function and clinical disorders arise when the axis is disrupted[1][2][3][5][6]. This axis is not a molecule, protein, receptor, or gene; instead, it is a biological network. For molecular targeting, refer to specific components such as the GnRH receptor, LH receptor, FSH receptor, or steroid receptors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hypothalamo-pituitary-gonadal axis (HPG axis).